Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Paul Bunn to Neoplasms

This is a "connection" page, showing publications Paul Bunn has written about Neoplasms.

 
Connection Strength
 
 
 
0.476
 
  1. Hirsch FR, Mok TS, Borges V, Bunn PA. Molecularly targeted therapy: when to stop and when to continue? Lancet Oncol. 2010 Aug; 11(8):709-11.
    View in: PubMed
    Score: 0.140
  2. Solomon B, Bunn PA. Clinical activity of pemetrexed: a multitargeted antifolate anticancer agent. Future Oncol. 2005 Dec; 1(6):733-46.
    View in: PubMed
    Score: 0.102
  3. Bunn PA. Implementing ASCO's strategic plan 2003: diverse membership needs, prevention, and patient partnerships. J Clin Oncol. 2003 Dec 01; 21(23 Suppl):231s-236s.
    View in: PubMed
    Score: 0.088
  4. Dinarello CA, Bunn PA. Fever. Semin Oncol. 1997 Jun; 24(3):288-98.
    View in: PubMed
    Score: 0.056
  5. Niyikiza C, Hanauske AR, Rusthoven JJ, Calvert AH, Allen R, Paoletti P, Bunn PA. Pemetrexed safety and dosing strategy. Semin Oncol. 2002 Dec; 29(6 Suppl 18):24-9.
    View in: PubMed
    Score: 0.021
  6. Calvert H, Bunn PA. Future directions in the development of pemetrexed. Semin Oncol. 2002 Apr; 29(2 Suppl 5):54-61.
    View in: PubMed
    Score: 0.020
  7. Bunn PA. Cancer and acquired immunodeficiency syndrome wasting syndromes: current and future therapies. Semin Oncol. 1998 Apr; 25(2 Suppl 6):1-3.
    View in: PubMed
    Score: 0.015
  8. Phelps RM, Johnson BE, Ihde DC, Gazdar AF, Carbone DP, McClintock PR, Linnoila RI, Matthews MJ, Bunn PA, Carney D, Minna JD, Mulshine JL. NCI-Navy Medical Oncology Branch cell line data base. J Cell Biochem Suppl. 1996; 24:32-91.
    View in: PubMed
    Score: 0.013
  9. Bunn PA. Letter: Should ineffective agents be used in combination chemotherapy? Cancer Chemother Rep. 1974 Mar-Apr; 58(2):127-8.
    View in: PubMed
    Score: 0.011
  10. Taylor CW, Chase EM, Whitehead RP, Rinehart JJ, Neidhart JA, Gonzalez R, Bunn PA, Hersh EM. A Southwest Oncology Group Phase I study of the sequential combination of recombinant interferon-gamma and recombinant interleukin-2 in patients with cancer. J Immunother (1991). 1992 Apr; 11(3):176-83.
    View in: PubMed
    Score: 0.010
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)